rac-(1S,2R,3S,4S)-bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid, 95.0%, 100g

(8-Benzyl-2,4-dioxo-1,3,8-triaza-spiro[4.5]dec-3-yl)-acetic acid, 95.0%, 500mg

4-NITRO-2-TRIFLUOROMETHYLTOLUENE, 95.0%, 25g

4,5-Dichloropyridin-3-amine, 95.0%, 5g

Syringe filters Minisart® NML Sterile (ETO-sterilised), 0,8 µm, 50 Piece(s)

(S)-5-methoxy-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, 98%, 1g

(5R)-1-(tert-butoxycarbonyl)-5-methyl-D-proline, 95.0%, 100mg

Lithium Bromide>99.0%(T)25g

Polydimethylsiloxanes, trimethylsiloxy terminated cSt 200, 100g

4-Fluoro-2-methylbenzo[d]oxazole, 97.0%, 250mg

(3R,4S)-4-Amino-1-methylpyrrolidin-3-ol dihydrochloride, 98%, 500mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)(methyl)amino)hexanoic acid, 98%, 250mg

3-(4-CHLOROPHENYL)-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRAZINE HCL, 95.0%, 1g